With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the expansion of its product portfolio with a comprehensive range of Additive Powders, to meet the rigorous demands of researchers and industrial manufacturers in additive ...Learn More

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of an advanced animal mRNA vaccine platform to accelerate the development of innovative and tailor-made vaccines for veterinary applications. This new ...Learn More

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its new Tumor Organoid & CAF Co-culture services to provide researchers with a more physiologically relevant in vitro tumor model, enabling a ...Learn More

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the launch of its custom Enzyme-Conjugated Particles synthesis services. These particles are primarily polymer- and inorganic-based, and biomolecules and enzymes can be ...Learn More

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the expansion of its custom services to include the synthesis of Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles (MNPs). These customized magnetic particles can be ...Learn More